Skip to main content

Media Category: Safety, Tolerability & Adherence

Generics and biosimilars in Multiple Sclerosis: understanding efficacy, safety and clinical confidence

Written by ParadigMS Foundation on .

Generics and biosimilars are becoming increasingly relevant in Multiple Sclerosis (MS) care as more follow-on treatments enter clinical practice. In this keynote, Thomas Berger explains how generics and biosimilars differ, how they are evaluated and approved, and why regulatory quality, bioequivalence, immunogenicity and pharmacovigilance are central to confidence in their use. Key Insights from the Lecture: Generics and biosimilars are already established in other areas of neurology, but their use in Multiple Sclerosis remains relatively recent. A major concern among both...

Continue reading

Safety tests in the clinical management of MS

Written by ParadigMS Foundation on .

Enhance your understanding of safety tests in the clinical management of MS with Prof. Tjalf Ziemssen and Prof. Magd Zakaria. This webinar explores the crucial role of safety monitoring in MS treatment, covering key topics such as liver enzyme and lymphocyte testing, ATZ monitoring, JCV testing for PML risk, and more. Watch the recording at your convenience and learn from the latest developments on optimising treatment strategies and ensuring patient safety. “Safety tests in the clinical management of MS“. Please subscribe to watch. Find out...

Continue reading

Comparative effectiveness, safety and persistence of ocrelizumab versus natalizumab in multiple sclerosis: A real-world, multi-center, propensity score-matched study.

Written by ParadigMS Foundation on .

Authors: Elena Barbutia∙ Alessia Castiellob ∙ Valeria Pozzillic ∙ Antonio Carotenutob ∙ Ilaria Tomassoa ∙ Marcello Mocciad ∙ Serena Ruggierie ∙ Giovanna Borriellof,g ∙ Roberta Lanzillob ∙ Vincenzo Brescia Morrab ∙ Carlo Pozzillia ∙ Maria Petraccaa. a. Department of Human Neurosciences, Sapienza University, Rome, Italy, b Department of Neurosciences, Reproductive Science and Odontostomatology, University of Naples “Federico II”, Naples, Italy, c. Unit of Neurology, Neurophysiology and Neurobiology, Campus Bio-Medico University, Rome, Italy, d Department of Molecular...

Continue reading

FAQs

Is ParadigMS for free?

Yes, a ParadigMS subscription is free for healthcare practitioniers. 

Do subscriptions auto-renew?
Your subscription will automatically renew on yearly basis. If you cancel your plan, it will not renew at the end of your subscription cycle. 
I am a representative from industry, can I subscribe?

Free subscriptions to ParadigMS are reserved for healthcare practitioners. If you are a representative of the industry please contact us on learning@paradigms.foundation and we would advise you how to get the access to the material. 

What happens if I subscribe as a HCP if I am not?
If you subscribe as a healthcare practitioner and it is proven that you are not a healthcare practitioner, we will cancel your subscription immediately. 
I am a patient, can I subscribe?

ParadigMS is designed specifically for healthcare practitioners, with content and language tailored to their professional needs. While patients cannot subscribe directly, we encourage you to consult your healthcare provider for relevant insights and updates that may benefit you.

Why should I subscribe to ParadigMS's e-platform?

Subscribing to ParadigMS’s e-platform gives you access to up-to-date information and valuable learning materials on multiple sclerosis and NMO, along with expert insights and the latest innovations in the field. It’s an essential resource for staying informed and enhancing your knowledge in MS care.

How can I cancel my subscription?
You can cancel your subscription in your account settings. 
Can I financially support ParadigMS?

Yes, you can financially support ParadigMS! We welcome donations to help us continue our mission of advancing multiple sclerosis education and research. Your contribution directly supports the creation of educational resources, expert discussions, and innovative projects in MS care. Visit our donation page to learn more about how you can make a difference: ParadigMS Donate.